The online home for the primary care professionals managing patients with cardiovascular disease, diabetes and related diseases.

Topic: Anticoagulation - Primary Care

Wednesday, 21 February 2018
Atrial fibrillation (AF) is the commonest sustained cardiac dysrhythmia, but is asymptomatic in about one quarter of patients. Case finding with subsequent assessment of the risk of stroke and bleeding are essential to ensure that the right patients receive appropriate intervention with oral anticoagulation.
Category: Editorial
Tuesday, 11 April 2017
Anticoagulation UK, in collaboration with other charities is hosting the Anticoagulation Achievement Awards 2017 to celebrate outstanding practice in the management, education and provision of anticoagulation across the UK.
Category: Have You Heard
Thursday, 28 April 2016
Recent guidelines recommend two key steps to reduce ischaemic stroke in people with atrial fibrillation: 1. Improving the assessment of stroke risk and 2. Increasing the use of evidence-based anticoagulant therapy. In this article, leading specialists explain how to apply current guidelines to improve current practice in stroke prevention.
Category: Editorial
Friday, 30 June 2017
The leading UK cardiovascular conference for the whole primary care team. Expert presenters and a down-to-earth approach help health professionals translate the latest evidence into daily practice and optimise patient care. Participants also receive 9 hours CPD credits. Book now to attend this inspirational event and take advantage of our Early Bird discount.
Category: Editorial
Wednesday, 07 June 2017
A new survey from the Atrial Fibrillation society shows a high level of demand for self-monitoring in people being treated with warfarin. In the survey, 79% of respondents said that they would prefer to self-monitor over clinic visits. New self- monitoring products are being launched.
Category: Have You Heard
Wednesday, 30 May 2018
Patients with atrial fibrillation (AF) still need treatment even after their heart rhythm seems to have returned to normal, according to a recent paper in the BMJ. They remain at a 60% greater risk of stroke or transient ischaemic attack (TIA) than patients without AF.
Friday, 19 May 2017
The direct factor Xa inhibitor rivaroxaban has been showing promise in trials in venous thromboembolism (VTE) and peripheral arterial disease (PAD). We provide details from the EINSTEIN CHOICE and COMPASS trials.
Saturday, 09 September 2017
A new study shows that long-term daily aspirin use in people aged ≥75 years, is linked to a higher than expected risk of disabling or fatal bleeding. While short-term aspirin use after a stroke or heart attack has clear benefits, the study authors say that older patients who take aspirin on a daily basis should also be prescribed a proton-pump inhibitor (PPI) to reduce the risk of bleeding.
Wednesday, 21 February 2018
The prevalence of atrial fibrillation (AF), together with the condition’s associated stroke and systemic thromboembolic risk, is increasing significantly. Fortunately, there are clear, evidence-based clinical guidelines and risk stratification tools, to ensure that patients can make informed choices about optimising their treatment and care.
Category: Editorial
Wednesday, 21 December 2016
Stroke related to atrial fibrillation can be prevented effectively through the use of anticoagulants. This article reviews recent guidelines, clinical trials and real-world evidence with non-vitamin K antagonist oral anticoagulants (NOACs) in patients with AF and provides practical guidance on the use of these newer agents in primary care.
Category: Editorial

Article search and filter